1例β-内酰胺类抗菌药物致中性粒细胞减少的病例分析(3)
[4] Olaison L， Relin L， Hogevik H， et al. Incidence of b-lactam induced delayed hypersensitivity and neutropenia during treatment of infective endocarditis[J]. Arch Intel Med， 1999， 159(6)： 607-615.
[5] Palmblad J. Drug-induced neutropenias： all are not alike[J]. Arch Intel Med， 2002， 162(11)： 1311-1312.
[6] Whitman CB， Joseph JM， Sjoholm LO. Cephalosporininduced leucopenia following rechallenge with cefoxitin[J]. Ann Pharmacother， 2008， 42(9)： 1327-1332.
[7] Benichou C， Solal Celigny P. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias： report of an international consensus meeting [J]. Nouv Rev Fr Hematol， 1991， 33(3)： 257-262.
[8] Andrès E， Maloisel F， Zimmer J. The role of haemtopoietic growth factors granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in the management of drug-induced agranulocytosis[J]. Br J Haematol， 2010， 150(1)： 3-8. (金知萍 蔡映云 陈璋璋)
[5] Palmblad J. Drug-induced neutropenias： all are not alike[J]. Arch Intel Med， 2002， 162(11)： 1311-1312.
[6] Whitman CB， Joseph JM， Sjoholm LO. Cephalosporininduced leucopenia following rechallenge with cefoxitin[J]. Ann Pharmacother， 2008， 42(9)： 1327-1332.
[7] Benichou C， Solal Celigny P. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias： report of an international consensus meeting [J]. Nouv Rev Fr Hematol， 1991， 33(3)： 257-262.
[8] Andrès E， Maloisel F， Zimmer J. The role of haemtopoietic growth factors granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in the management of drug-induced agranulocytosis[J]. Br J Haematol， 2010， 150(1)： 3-8. (金知萍 蔡映云 陈璋璋)